DOCSLIB.ORG

Complete Thesis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Complete Thesis University of Groningen Brain death and organ donation Hoeksma, Dane IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2017 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Hoeksma, D. (2017). Brain death and organ donation: Observations and interventions. Rijksuniversiteit Groningen. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 28-09-2021 Brain Death and Organ Donation Observations and Interventions Dane Hoeksma Brain Death and Organ Donation Observations and Interventions Proefschrift ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen Dane Hoeksma op gezag van de PhD-thesis rector magnifcus prof. dr. E. Sterken en volgens besluit van het College voor Promoties. This PhD-project was fnancially supported by De openbare verdediging zal plaatsvinden op University Medical Center Groningen woensdag 6 september 2017 om 12.45 uur Junior Scientifc Masterclass, Faculty of medicine University Of Groningen Research Institute GUIDE door The printing of this thesis was kindly supported by: University Medical Center Groningen Research Institute GUIDE Noord-Negentig B.V. Chipsoft B.V. Dane Hoeksma geboren op 14 februari 1988 Cover and invitation: Anne van Erp and Dane Hoeksma te Ispingo, Zuid-Afrika Layout: Rens Dommerholt, Persoonlijk Proefschrift, www.persoonlijkproefschrift.nl Printing: Ipskamp printing, www.ipskampprinting.nl Copyright: Dane Hoeksma, 2017-06-11 ISBN number: 978-94-028-0690-8 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form without explicit prior permission of the author. Promotores Paranimfen Prof. dr. H.G.D. Leuvenink M. Kirschbaum Prof. dr. H. van Goor R. Mencke Beoordelingscommissie Prof. dr. J.L. Hillebrands Prof. dr. D.J. Reijngoud Prof. dr. B. Yard CONTENTS Chapter 1 Introduction 9 Chapter 2 Slow induction of brain death leads to decreased renal function and increased hepatic apoptosis in brain-dead rats 21 Chapter 3 Quality of donor lung grafts: A comparative study between explosive and gradual brain death induction models in rats 41 Chapter 4 Inadequate anti-oxidative responses in kidneys of brain-dead rats 55 Chapter 5 Differences between kidney and liver perfusion, oxygen consumption, and metabolism during brain death 73 Chapter 6 MnTMPyP, a selective superoxide dismutase mimetic, reduces oxidative stress in kidneys of brain-dead rats 95 Chapter 7 MnTMPyP treatment of brain-dead rats leads to improved renal function during ex vivo reperfusion 115 Chapter 8 Discussion and future perspectives 129 Chapter 9 English and Dutch summary 137 List of abbreviations 146 Author affliations 151 Acknowledgments 152 Biography 157 CHAPTER Introduction 1 CHAPTER 1 INTRODUCTION Renal transplantation is the most effective therapy for end-stage renal disease. In 2015, 442 kidneys from deceased donors, the largest donor pool, were transplanted in the Graft survival 1 1 Netherlands . At the end of this year, 554 patients were still awaiting a kidney transplant. 100 1 The total amount of kidneys transplanted in the Eurotransplant region was 3206 in the year LD kidney 2015 while 10400 patients were waiting for a kidney transplant. In the United states, 17.107 80 DBD kidney kidney transplants were performed while 100.791 patients were still on the waiting list2,3. DCD kidney These data indicate that the demand of donor organs outweighs the supply. Therefore, an 60 increase in donor organs is necessary to meet the pressing demand. 40 Kidneys can be retrieved from living donors (LD) and deceased donors. Between the two, deceased donors form the majority since living donors are scarce4. Deceased donors can Percent survival 20 be classifed into deceased brain-dead (DBD) and deceased circulatory death donors 0 5 (DCD) . Of the kidneys transplanted from deceased donors, most are retrieved from 0 5 10 15 20 25 brain-dead donors. However, in many countries, the number of kidneys obtained from Years DCD donors are increasing and in some countries, like the Netherlands, these kidneys Figure 1. Renal graft survival in transplant recipients transplanted between 1993 and 2015 in the University are already transplanted as frequently as DBD kidneys. This is because increased amounts Medical Center Groningen. Graft survival is superior when organs are retrieved from living donors (LD) compared of kidneys from DCD donors who die unexpectedly are being more frequently used for to deceased donors. Within the deceased donor group, organs retrieved from brain-dead donors (DBD) show transplantation. Most DCD donor kidneys used for transplantation are from donors who superior graft survival compared to cardiac-death donors (DCD). die expectedly in the sense that cardiac arrest is anticipated. In the future, an increased amount of DCD donors could be realized as some countries are starting to use organs from unexpected DCD donors. There are different options to meet the increasing demand for donor organs. Many countries have resorted to the use of expanded criteria donors (ECD) to meet the increased 6 The outcome of kidneys retrieved from different donor types varies. The graft survival rates demand of donor organs . ECD donors are older donors (>60 years) or donors aged 50 of kidneys from different donor types from the University Medical Center Groningen are to 59 years with two of the following: cerebrovascular accident as the cause of death, pre- depicted in Figure 1. Kidneys from living donors are superior to deceased donor kidneys existing hypertension, or terminal serum creatinine greater than 1.5 mg/dl. In the future, which can be explained by shorter warm- and cold ischemia times. DBD kidneys do not more ECD donors will be evident due to the aging population. Regarding DCD donors, suffer warm ischemia but are usually subjected to long periods of cold ischemia during an increased amount of DCD donors could be realized by increased use of organs from transport. In addition to cold ischemia, DCD kidneys usually suffer prolonged periods of unexpected DCD. In Spain and Russia, kidneys from unexpected DCD donors are being 7-9 warm ischemia which results in the worst outcomes amongst the three donor types. This increasingly used . Unexpected DCD donors form a large group and may represent a effect is typically observed soon after transplantation as the incidence of primary non- potential option to decrease the demand for donor kidneys. function (PNF) of DCD grafts is 9%, while DBD and LD grafts show PNF rates of 5 and 1%, respectively. However, overall graft survival of DCD-, DBD- and LD transplantation Transplanting kidneys from more marginal donors like ECD and DCD donors is likely to is 86%, 86% and 93%, respectively. Therefore, outcomes from LD kidneys is superior to be associated with decreased rates of graft survival. Therefore, developing strategies to deceased donors but overall outcome is not compromised between either two deceased improve graft survival rates of transplanted kidneys could be advantageous. By doing donor types. However, short term outcome of DCD kidneys is inferior compared to DBD so, these strategies could result in increased graft survival and thereby prevent patients kidneys with regard to, like mentioned above, PNF, but also delayed graft function (DGF; from being relisted on the kidney waiting list. These strategies could also beneft more 82% and 30%, respectively). Yet, despite that deceased donation infuences graft survival conventional donor types such as DBD donors as these kidneys suffer numerous insults in negatively, transplanting deceased donor kidneys represent a good solution for patients the donor. Furthermore, all transplants are subjected to ischemia-reperfusion (I-R) injury with end stage renal disease as the ten-year graft survival rate exceeds 85%. during the transplantation process and therefore even LD donor kidneys could beneft from such strategies. A major break-through was evident with the benefcial effect of machine perfusion on graft survival of deceased donor kidney transplants compared to cold storage10. As mentioned above, kidneys from brain-dead donors lead to inferior outcomes compared to kidneys from living donation4. This phenomenon is related to pathophysiological changes that take place in the brain-dead donor. Brain death (BD) leads to major hemodynamic derailments, systemic infammation, and altered metabolism which potentially affects future donor organs11-13. Furthermore, brain dead donor organs suffer increased I-R injury 14. Major hemodynamic derailments are due to the catecholamine storm which is characteristic for the onset of BD13. The catecholamine storm is believed to be the bodies fnal attempt to maintain cerebral perfusion against increasing intracranial pressure. The 10 11 CHAPTER 1 INTRODUCTION large amounts of secreted catecholamines lead to severe vasoconstriction and possible mitochondrial electron transport chain (ETC), by xanthine and NADPH oxidase, the ischemic damage to organs15. Furthermore, spinal cord ischemia will result in vascular tricarboxylic acid (TCA) cycle enzymes aconitase and α-ketoglutarate dehydrogenase, 1 collapse and consequently decreased blood fow and increased ischemia. Circulating by non-TCA cycle enzymes and by monoamine oxidases and cytochrome b5 reductase, 1 cytokines are evident soon after the onset of BD with IL-6 being the most implicated located in the outer mitochondrial membrane39.
Load more

Recommended publications
  • Picrotoxin-Like Channel Blockers of GABAA Receptors
    COMMENTARY Picrotoxin-like channel blockers of GABAA receptors Richard W. Olsen* Department of Molecular and Medical Pharmacology, Geffen School of Medicine, University of California, Los Angeles, CA 90095-1735 icrotoxin (PTX) is the prototypic vous system. Instead of an acetylcholine antagonist of GABAA receptors (ACh) target, the cage convulsants are (GABARs), the primary media- noncompetitive GABAR antagonists act- tors of inhibitory neurotransmis- ing at the PTX site: they inhibit GABAR Psion (rapid and tonic) in the nervous currents and synapses in mammalian neu- system. Picrotoxinin (Fig. 1A), the active rons and inhibit [3H]dihydropicrotoxinin ingredient in this plant convulsant, struc- binding to GABAR sites in brain mem- turally does not resemble GABA, a sim- branes (7, 9). A potent example, t-butyl ple, small amino acid, but it is a polycylic bicyclophosphorothionate, is a major re- compound with no nitrogen atom. The search tool used to assay GABARs by compound somehow prevents ion flow radio-ligand binding (10). through the chloride channel activated by This drug target appears to be the site GABA in the GABAR, a member of the of action of the experimental convulsant cys-loop, ligand-gated ion channel super- pentylenetetrazol (1, 4) and numerous family. Unlike the competitive GABAR polychlorinated hydrocarbon insecticides, antagonist bicuculline, PTX is clearly a including dieldrin, lindane, and fipronil, noncompetitive antagonist (NCA), acting compounds that have been applied in not at the GABA recognition site but per- huge amounts to the environment with haps within the ion channel. Thus PTX major agricultural economic impact (2). ͞ appears to be an excellent example of al- Some of the other potent toxicants insec- losteric modulation, which is extremely ticides were also radiolabeled and used to important in protein function in general characterize receptor action, allowing and especially for GABAR (1).
    [Show full text]
  • Qrno. 1 2 3 4 5 6 7 1 CP 2903 77 100 0 Cfcl3
    QRNo. General description of Type of Tariff line code(s) affected, based on Detailed Product Description WTO Justification (e.g. National legal basis and entry into Administration, modification of previously the restriction restriction HS(2012) Article XX(g) of the GATT, etc.) force (i.e. Law, regulation or notified measures, and other comments (Symbol in and Grounds for Restriction, administrative decision) Annex 2 of e.g., Other International the Decision) Commitments (e.g. Montreal Protocol, CITES, etc) 12 3 4 5 6 7 1 Prohibition to CP 2903 77 100 0 CFCl3 (CFC-11) Trichlorofluoromethane Article XX(h) GATT Board of Eurasian Economic Import/export of these ozone destroying import/export ozone CP-X Commission substances from/to the customs territory of the destroying substances 2903 77 200 0 CF2Cl2 (CFC-12) Dichlorodifluoromethane Article 46 of the EAEU Treaty DECISION on August 16, 2012 N Eurasian Economic Union is permitted only in (excluding goods in dated 29 may 2014 and paragraphs 134 the following cases: transit) (all EAEU 2903 77 300 0 C2F3Cl3 (CFC-113) 1,1,2- 4 and 37 of the Protocol on non- On legal acts in the field of non- _to be used solely as a raw material for the countries) Trichlorotrifluoroethane tariff regulation measures against tariff regulation (as last amended at 2 production of other chemicals; third countries Annex No. 7 to the June 2016) EAEU of 29 May 2014 Annex 1 to the Decision N 134 dated 16 August 2012 Unit list of goods subject to prohibitions or restrictions on import or export by countries- members of the
    [Show full text]
  • Fluorides in the Environment
    Color profile: Disabled Composite 150 lpi at 45 degrees Fluorides in the Environment A4662 - Weinstein - Vouchers - VP10 #K.prn 1 Z:\Customer\CABI\A4642 - Weinstein\A4662 - Weinstein - Vouchers - VP10 #K.vp Monday, November 10, 2003 3:35:50 PM Color profile: Disabled Composite 150 lpi at 45 degrees A4662 - Weinstein - Vouchers - VP10 #K.prn 2 Z:\Customer\CABI\A4642 - Weinstein\A4662 - Weinstein - Vouchers - VP10 #K.vp Monday, November 10, 2003 3:35:50 PM Color profile: Disabled Composite 150 lpi at 45 degrees Fluorides in the Environment Effects on Plants and Animals Professor L.H. Weinstein Boyce Thompson Institute for Plant Research Tower Road Ithaca NY 14853 USA and Professor A. Davison School of Biology Ridley Building University of Newcastle Newcastle upon Tyne NE1 7RU UK CABI Publishing A4662 - Weinstein - Vouchers - VP10 #K.prn 3 Z:\Customer\CABI\A4642 - Weinstein\A4662 - Weinstein - Vouchers - VP10 #K.vp Monday, November 10, 2003 3:35:51 PM Color profile: Disabled Composite 150 lpi at 45 degrees CABI Publishing is a division of CAB International CABI Publishing CABI Publishing CAB International 875 Massachusetts Avenue Wallingford 7th Floor Oxon OX10 8DE Cambridge, MA 02139 UK USA Tel: +44 (0)1491 832111 Tel: +1 617 395 4056 Fax: +44 (0)1491 833508 Fax: +1 617 354 6875 E-mail: [email protected] E-mail: [email protected] Web site: www.cabi-publishing.org ©L.H. Weinstein and A. Davison 2004. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronically, mechanically, by photocopying, recording or otherwise, without the prior permission of the copyright owners.
    [Show full text]
  • CAS Number Index
    2334 CAS Number Index CAS # Page Name CAS # Page Name CAS # Page Name 50-00-0 905 Formaldehyde 56-81-5 967 Glycerol 61-90-5 1135 Leucine 50-02-2 596 Dexamethasone 56-85-9 963 Glutamine 62-44-2 1640 Phenacetin 50-06-6 1654 Phenobarbital 57-00-1 514 Creatine 62-46-4 1166 α-Lipoic acid 50-11-3 1288 Metharbital 57-22-7 2229 Vincristine 62-53-3 131 Aniline 50-12-4 1245 Mephenytoin 57-24-9 1950 Strychnine 62-73-7 626 Dichlorvos 50-23-7 1017 Hydrocortisone 57-27-2 1428 Morphine 63-05-8 127 Androstenedione 50-24-8 1739 Prednisolone 57-41-0 1672 Phenytoin 63-25-2 335 Carbaryl 50-29-3 569 DDT 57-42-1 1239 Meperidine 63-75-2 142 Arecoline 50-33-9 1666 Phenylbutazone 57-43-2 108 Amobarbital 64-04-0 1648 Phenethylamine 50-34-0 1770 Propantheline bromide 57-44-3 191 Barbital 64-13-1 1308 p-Methoxyamphetamine 50-35-1 2054 Thalidomide 57-47-6 1683 Physostigmine 64-17-5 784 Ethanol 50-36-2 497 Cocaine 57-53-4 1249 Meprobamate 64-18-6 909 Formic acid 50-37-3 1197 Lysergic acid diethylamide 57-55-6 1782 Propylene glycol 64-77-7 2104 Tolbutamide 50-44-2 1253 6-Mercaptopurine 57-66-9 1751 Probenecid 64-86-8 506 Colchicine 50-47-5 589 Desipramine 57-74-9 398 Chlordane 65-23-6 1802 Pyridoxine 50-48-6 103 Amitriptyline 57-92-1 1947 Streptomycin 65-29-2 931 Gallamine 50-49-7 1053 Imipramine 57-94-3 2179 Tubocurarine chloride 65-45-2 1888 Salicylamide 50-52-2 2071 Thioridazine 57-96-5 1966 Sulfinpyrazone 65-49-6 98 p-Aminosalicylic acid 50-53-3 426 Chlorpromazine 58-00-4 138 Apomorphine 66-76-2 632 Dicumarol 50-55-5 1841 Reserpine 58-05-9 1136 Leucovorin 66-79-5
    [Show full text]
  • Altschul2018.Pdf (3.396Mb)
    This thesis has been submitted in fulfilment of the requirements for a postgraduate degree (e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following terms and conditions of use: This work is protected by copyright and other intellectual property rights, which are retained by the thesis author, unless otherwise stated. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the author. The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the author. When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given. Chimpanzee personality and its relations with cognition and health: a comparative perspective Drew Altschul Thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy in Psychology to The University of Edinburgh July 2017 Declaration I hereby declare that this thesis is of my own composition, and that it contains no material previously submitted for the award of any other degree. The work reported in this thesis has been executed by myself, except where due acknowledgement is made in the text. Signed, Drew Altschul i Acknowledgements This research was funded in part by The University of Edinburgh’s Principal Career Development Scholarships, the Great Britain Sasakawa Foundation, and the Department of Psychology and many research support grants. There are many people to whom I owe thanks, for the completion of this thesis would not have been possible without them.
    [Show full text]
  • CHIMPANZEE (Pan Troglodytes ) CARE MANUAL
    CHIMPANZEE (Pan troglodytes) CARE MANUAL CREATED BY THE AZA Chimpanzee Species Survival Plan® IN ASSOCIATION WITH THE AZA Ape Taxon Advisory Group Chimpanzee (Pan Troglodytes) Care Manual Chimpanzee (Pan troglodytes) Care Manual Published by the Association of Zoos and Aquariums in association with the AZA Animal Welfare Committee Formal Citation: AZA Ape TAG 2010. Chimpanzee (Pan troglodytes) Care Manual. Association of Zoos and Aquariums, Silver Spring, MD. Original Completion Date: December 8, 2009 Authors and Significant Contributors: Steve Ross, Ph.D. Lincoln Park Zoo Jennie McNary, Los Angeles Zoo See Appendix F for a full list of contributors and reviewers from the AZA Chimpanzee SSP. Reviewers: Linda Brent, Ph.D., Chimp Haven, Inc. Maria Finnigan, Perth Zoo, ASMP Chimpanzee Coordinator Steve Ross, Ph.D., Lincoln Park Zoo Candice Dorsey, Ph.D., AZA Director, Animal Conservation Debborah Colbert, Ph.D., AZA VP, Animal Conservation Paul Boyle, Ph.D., AZA Sr. VP Conservation and Education See Appendix F for a full list of contributors and reviewers from the AZA Chimpanzee SSP. Chimpanzee Care Manual Project Consultant: Joseph C.E. Barber, Ph.D. AZA Staff Editors: Candice Dorsey, Ph.D., Director, Animal Conservation Cover Photo Credits: Steve Ross Disclaimer: This manual presents a compilation of knowledge provided by recognized animal experts based on the current science, practice, and technology of animal management. The manual assembles basic requirements, best practices, and animal care recommendations to maximize capacity for excellence in animal care and welfare. The manual should be considered a work in progress, since practices continue to evolve through advances in scientific knowledge. The use of information within this manual should be in accordance with all local, state, and federal laws and regulations concerning the care of animals.
    [Show full text]
  • Human Pharmacokinetic Study of Tutin in Honey; a Plant-Derived Neurotoxin ⇑ Barry A
    Food and Chemical Toxicology 72 (2014) 234–241 Contents lists available at ScienceDirect Food and Chemical Toxicology journal homepage: www.elsevier.com/locate/foodchemtox Human pharmacokinetic study of tutin in honey; a plant-derived neurotoxin ⇑ Barry A. Fields a, , John Reeve b, Andrew Bartholomaeus c,d, Utz Mueller a a Food Standards Australia New Zealand, 55 Blackall St., Barton, ACT 2600, Australia b New Zealand Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington, New Zealand c Therapeutics Research Centre, School of Medicine, University of Queensland, Queensland, Australia d School of Pharmacy, Faculty of Health, University of Canberra, Australia article info abstract Article history: Over the last 150 years a number of people in New Zealand have been incapacitated, hospitalised, or died Received 26 March 2014 from eating honey contaminated with tutin, a plant-derived neurotoxin. A feature of the most recent poi- Accepted 16 July 2014 soning incident in 2008 was the large variability in the onset time of clinical signs and symptoms of tox- Available online 30 July 2014 icity (0.5–17 h). To investigate the basis of this variability a pharmacokinetic study was undertaken in which 6 healthy males received a single oral dose of tutin-containing honey giving a tutin dose of Keywords: 1.8 lg/kg body weight. The serum concentration–time curve for all volunteers exhibited two discrete Tutin peaks with the second and higher level occurring at approximately 15 h post-dose. Two subjects reported Neurotoxin mild, transient headache at a time post-dose corresponding to maximum tutin concentrations. There Glycosides Honey were no other signs or symptoms typical of tutin intoxication such as nausea, vomiting, dizziness or sei- Coriaria arborea zures.
    [Show full text]
  • Accepted Version
    Article Metabolomics identifies a biomarker revealing in vivo loss of functional ß-cell mass before diabetes onset LI, Lingzi, et al. Abstract Identification of pre-diabetic individuals with decreased functional ß-cell mass is essential for the prevention of diabetes. However, in vivo detection of early asymptomatic ß-cell defect remains unsuccessful. Metabolomics emerged as a powerful tool in providing read-outs of early disease states before clinical manifestation. We aimed at identifying novel plasma biomarkers for loss of functional ß-cell mass in the asymptomatic pre-diabetic stage. Non-targeted and targeted metabolomics were applied on both lean ß-Phb2-/- mice (ß-cell-specific prohibitin-2 knockout) and obese db/db mice (leptin receptor mutant), two distinct mouse models requiring neither chemical nor diet treatments to induce spontaneous decline of functional ß-cell mass promoting progressive diabetes development. Non-targeted metabolomics on ß-Phb2-/- mice identified 48 and 82 significantly affected metabolites in liver and plasma, respectively. Machine learning analysis pointed to deoxyhexose sugars consistently reduced at the asymptomatic pre-diabetic stage, including in db/db mice, showing strong correlation with the gradual loss of ß-cells. [...] Reference LI, Lingzi, et al. Metabolomics identifies a biomarker revealing in vivo loss of functional ß-cell mass before diabetes onset. Diabetes, 2019, vol. 68, no. 12, p. 2272-2286 PMID : 31537525 DOI : 10.2337/db19-0131 Available at: http://archive-ouverte.unige.ch/unige:126176
    [Show full text]
  • Biology, Medicine, and Surgery of Elephants
    BIOLOGY, MEDICINE, AND SURGERY OF ELEPHANTS BIOLOGY, MEDICINE, AND SURGERY OF ELEPHANTS Murray E. Fowler Susan K. Mikota Murray E. Fowler is the editor and author of the bestseller Zoo Authorization to photocopy items for internal or personal use, or and Wild Animal Medicine, Fifth Edition (Saunders). He has written the internal or personal use of specific clients, is granted by Medicine and Surgery of South American Camelids; Restraint and Blackwell Publishing, provided that the base fee is paid directly to Handling of Wild and Domestic Animals and Biology; and Medicine the Copyright Clearance Center, 222 Rosewood Drive, Danvers, and Surgery of South American Wild Animals for Blackwell. He is cur- MA 01923. For those organizations that have been granted a pho- rently Professor Emeritus of Zoological Medicine, University of tocopy license by CCC, a separate system of payments has been California-Davis. For the past four years he has been a part-time arranged. The fee codes for users of the Transactional Reporting employee of Ringling Brothers, Barnum and Bailey’s Circus. Service are ISBN-13: 978-0-8138-0676-1; ISBN-10: 0-8138-0676- 3/2006 $.10. Susan K. Mikota is a co-founder of Elephant Care International and the Director of Veterinary Programs and Research. She is an First edition, 2006 author of Medical Management of the Elephants and numerous arti- cles and book chapters on elephant healthcare and conservation. Library of Congress Cataloging-in-Publication Data © 2006 Blackwell Publishing Elephant biology, medicine, and surgery / edited by Murray E. All rights reserved Fowler, Susan K. Mikota.—1st ed.
    [Show full text]
  • Assessment of Neuronal Activity Using Microelectrode Array
    In vitro Toxicology eCiphr®Neuro: Assessment of Neuronal Activity Using Microelectrode Array Background Information Protocol • The eCiphr®Neuro assay uses primary Cell Type cultures of rat cortical neurons. Primary rat cortical neurons • Cyprotex’s neuronal assay uses Analysis Platform high throughput microelectrode Maestro 48-well MEA system (Axion BioSystems) array (MEA) technology to monitor electrophysiological activity. Test Article Concentrations 4 concentrations in triplicate (dependent on customer requirements) • Neurons grown on microelectrode arrays recapitulate many features of Quality Controls neurons in vivo, including spontaneous Negative control: 0.2% DMSO (vehicle) activity (spiking and bursting), plasticity, ‘The unique capabilities of Positive controls: picrotoxin and domoic organisation and responsiveness to a MEAs to provide functional acid (at single concentration) wide range of neurotransmitters and measurements of network pharmacological agonists/antagonists1. activity, including spontaneous Data Delivery Firing rate (spikes/second) activity, evoked activity, and • This technology provides a unique Burst rate (spikes/second) responses to pharmacological in vitro system for preclinical drug Number of spikes in burst challenges, therefore offers an discovery, neurotoxicity assessment and Percent of isolated spikes advantage over other potential disease modelling. Coefficient of variation (CV) of the inter-spike screening approaches that rely intervals (ISI) on biochemical or structural Burst duration endpoints.’ Normalised IQR (inter-quartile range) burst duration 1Robinette BL et al., (2011) Front Interburst interval Neuroeng 4; 1-9 Mean ISI-distance (measure of synchrony) Normalised Median Absolute Deviation (MAD) burst spike number Median ISI/Mean ISI To find out more [email protected] In vitro networks of neurons are spontaneously active and express patterns of electrical activity as part of their normal function2.
    [Show full text]
  • Modeling the Health of Free-Living Illinois Herptiles: an Integrated Approach Incorporating Environmental, Physiologic, Spatiotemporal, and Pathogen Factors
    MODELING THE HEALTH OF FREE-LIVING ILLINOIS HERPTILES: AN INTEGRATED APPROACH INCORPORATING ENVIRONMENTAL, PHYSIOLOGIC, SPATIOTEMPORAL, AND PATHOGEN FACTORS BY LAURA ADAMOVICZ DISSERTATION Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in VMS-Comparative Biosciences in the Graduate College of the University of Illinois at Urbana-Champaign, 2019 Urbana, Illinois Doctoral Committee: Assistant Professor Matthew Allender, Chair and Research Director Professor CheMyong Jay Ko Associate Professor Megan Mahoney Assistant Professor Rebecca Smith Professor Mark Mitchell, Louisiana State University Sharon Deem, Saint Louis Zoo Institute for Conservation Medicine ABSTRACT Human expansion has contributed to an unprecedented global environmental crisis and significantly impacted the stability of many wildlife populations. The health of wildlife populations influences their ability to recover from a complex array of anthropogenic and natural stressors. Promotion of positive health status may improve conservation outcomes in wild animals. However, wildlife health status is dynamic and determined by a variety of factors. Studying such a complex system requires a comprehensive approach with careful consideration of multiple determinants simultaneously. The purpose of this dissertation is to holistically characterize health in three herptile species of conservation concern in Illinois by combining traditional veterinary health assessments with environmental and spatio-temporal data within a modeling framework. The main objective is to identify the best means of assessing wellness in wild herptiles to inform management strategies which support robust population health. Health was investigated in three species of conservation concern in Illinois: the eastern box turtle (Terrapene carolina carolina), the ornate box turtle (Terrapene ornata ornata), and the silvery salamander (Ambystoma platineum) over the course of three years using a combination of physical examination, qPCR pathogen screening, and clinical pathology (box turtles).
    [Show full text]
  • P1029 Tutin Risk Assessment
    Supporting document 1 Risk assessment – Proposal P1029 Maximum Level for Tutin in Honey Executive summary Tutin is a plant-derived neurotoxin which is sometimes detected in New Zealand honey. Tutin contamination of honey occurs when bees gather honeydew from an insect that feeds on sap of the shrub Coriaria arborea (“tutu”). Consumption of tutu honeydew honey can result in serious acute adverse health effects. Temporary maximum levels (MLs) for tutin in honey and comb honey of 2 mg/kg and 0.1 mg/kg, respectively, currently exist in the Australia New Zealand Food Standards Code (Standard 1.4.1 – Contaminants and Natural Toxicants). For acute neurotoxins, such as tutin, severe symptoms of poisoning (e.g. tonic-clonic convulsions) usually correspond to the time taken to achieve their maximal concentration in serum (typically less than 3-4 hours after ingestion). However, the large variability in the onset time of clinical signs and symptoms of toxicity (0.5 to 17 h with a median of 7.5 h) following tutu honeydew honey ingestion in the 2008 human poisoning incident was difficult to explain. To investigate this variability, which was considered to have potential implications for the existing MLs for tutin, a human pharmacokinetic study was conducted in which 6 healthy adult males each received a single oral dose of tutu honeydew honey. The tutin dose received by the volunteers was equivalent to that received by a high consumer of honey (97.5th percentile) that contains tutin at the ML of 2 mg/kg. The serum tutin concentration profile for all volunteers exhibited two discrete peaks, with the first at 0.5 to 1.5 hours post-dose, and the second and higher serum level occurring at 8 to 16 hours post-dose.
    [Show full text]